Carl Barnes Comments on Earnout Disputes in Startup Acquisitions in Wall Street Journal

The Wall Street Journal article "Rise of 'Earnouts' Muddies M&A Waters" discusses the increasing landscape of earnout agreements in startup acquisitions. As the article states, earnout agreements are often used in order to settle differences over a company's valuation, but are frequently leading to disputes over milestone payments. MBBP corporate partner Carl Barnes remarks that: …

Continue reading Carl Barnes Comments on Earnout Disputes in Startup Acquisitions in Wall Street Journal

MBBP’s Life Sciences Vector Newsletter, Summer 2017

Our Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL On September 26, corporate partner Mike Jabbawy will take part in the panel “How …

Continue reading MBBP’s Life Sciences Vector Newsletter, Summer 2017

More Money for Life Sciences?

By: Erin Bryan A new legislative proposal to provide a five-year, $500 million life sciences initiative was recently announced by Governor Charlie Baker. This initiative would extend the current 10-year, $1 billion initiative that is set to expire at the end of the next fiscal year and would continue to be managed by the Massachusetts …

Continue reading More Money for Life Sciences?

David Sabatini To Be Awarded 2017 Dickson Prize in Medicine

Biologist David Sabatini of MBBP client Whitehead Institute will receive the University of Pittsburgh's 2017 Dickson Prize in Medicine. The Dickson Prize in Medicine is awarded annually to a leading American investigator who is engaged in innovative, paradigm-shifting biomedical research. Sabatini discovered mTOR, a key cellular regulatory metabolic pathway. In addition to being a member of …

Continue reading David Sabatini To Be Awarded 2017 Dickson Prize in Medicine

iSpecimen Unveils Online Biospecimen Marketplace

Firm client iSpecimen has launched an online biospecimen marketplace for the life sciences industry. The company hopes that the marketplace will alleviate scientists' difficulty in finding high-quality samples of human material necessary to conduct research. The marketplace compiles available samples and allows users to search by patient information. Users can then order the corresponding materials. …

Continue reading iSpecimen Unveils Online Biospecimen Marketplace

MBBP’s Life Sciences Vector Newsletter, Spring 2017

Our Life Sciences team has published the Spring 2017 edition of its newsletter, Vector. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. DAVID CZARNECKI AND STANLEY CHALVIRE ELEVATED WITHIN THE FIRM We are pleased to announce that David Czarnecki and Stanley Chalvire …

Continue reading MBBP’s Life Sciences Vector Newsletter, Spring 2017

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Early-Stage Life Science Financing: Event Recap

By: Erin Bryan On Thursday, March 30th, MBBP kicked off an Innovations in Life Sciences event at the Cambridge Innovation Center by hosting a panel entitled "Money and Molecules: Early-Stage Life Science Financing". The panel included Jeffrey Arnold, President & CEO of Arnold Strategies, LLC; Timothy Sullivan, Partner at Aju IB Investment; John Tagliamonte who serves …

Continue reading Early-Stage Life Science Financing: Event Recap

Early-Stage Life Science Financing Event – March 30

Don't miss our next event, Money and Molecules: Early-Stage Life Science Financing, on Thursday, March 30 from 3:30-5pm at the Cambridge Innovation Center. Moderated by corporate attorney John Hession, a panel of experts will discuss the current complex financing environment for early-stage life science companies. Among other topics, the panel discussion will include: Formulate a …

Continue reading Early-Stage Life Science Financing Event – March 30

MBBP client, Whitehead Institute, featured in New York Times article discussing Genomic research

The Whitehead Institute for Biomedical Research, a client of MBBP, is featured in a New York Times article about progressive research on topologically associating domains (TADs) in DNA. As the article explains, TADs are a newly discovered design feature of the genome that partition different groups of genes into neighborhoods. If these partitions are broken, various …

Continue reading MBBP client, Whitehead Institute, featured in New York Times article discussing Genomic research